Steven R. Loranger is Director at Xylem Inc. (XYL). They have made 30 open-market trades across 5 companies since 2006, most recently 2026-05-08.
CIK 0001226924
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $1.6M since 2006, against 23 sales. Across 7 scored buys the stock is down 0.0% at ninety days, and 0.8 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 0% | 14% |
| Avg Move | -9.4% | -2.9% | -0.0% |
| Alpha | -4.6% | -2.4% | -0.8% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL | 2025-02-14 | 2025-02-14 | $76.42 | $877K | -5.9% | -6.9% | +1.3% |
| XYL | SELL | 2020-09-11 | 2020-09-15 | $83.95 | $3.1M | -1.8% | +7.5% | +14.8% |
| XYL | SELL | 2020-02-12 | 2020-02-14 | $88.61 | $2.7M | -8.3% | -26.1% | -33.0% |
| XYL | SELL | 2019-03-15 | 2019-03-18 | $76.99 | $770K | +0.2% | +4.9% | +2.1% |
| XYL | SELL | 2017-12-19 | 2017-12-20 | $68.12 | $2.0M | +1.0% | +5.4% | +15.8% |
| XYL | SELL | 2017-12-18 | 2017-12-19 | $68.10 | $6.5M | -0.2% | +4.2% | +14.6% |
| XYL | SELL · 10b5-1 | 2017-12-13 | 2017-12-15 | $68.02 | $14K | +0.3% | +3.7% | +14.1% |
| XYL | SELL · 10b5-1 | 2017-12-11 | 2017-12-13 | $68.23 | $13K | +0.0% | +4.4% | +15.5% |
| XYL | SELL | 2017-11-06 | 2017-11-08 | $66.25 | $2.5M | +1.3% | +3.1% | +7.9% |
| XYL | SELL | 2017-06-28 | 2017-06-30 | $55.01 | $4.2M | +0.1% | +1.7% | +11.9% |
| XYL | SELL | 2016-08-11 | 2016-08-12 | $48.13 | $1.4M | +3.0% | +1.2% | +7.2% |
| XYL | SELL | 2016-08-10 | 2016-08-12 | $48.11 | $1.6M | +3.0% | +1.2% | +7.2% |
| XYL | SELL | 2016-07-28 | 2016-08-01 | $48.01 | $3.1M | +4.1% | +9.1% | +3.6% |
| XYL | SELL | 2016-06-01 | 2016-06-02 | $44.52 | $2.2M | +1.0% | -0.8% | +12.5% |
| XYL | SELL | 2016-05-27 | 2016-05-31 | $44.67 | $2.2M | +3.6% | +0.7% | +15.0% |
| EW | BUY | 2016-05-24 | 2016-05-26 | $101.07 | $1.0M | +2.7% | -5.4% | +14.4% |
| XYL | SELL | 2015-11-04 | 2015-11-06 | $36.69 | $6.1M | -7.1% | +0.4% | +3.2% |
| XYL | SELL | 2014-11-12 | 2014-11-13 | $37.51 | $3.8M | -7.1% | +0.4% | +0.4% |
| XYL | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $36.08 | $3.2M | -7.1% | +0.4% | +0.4% |
| XLS | SELL | 2012-12-19 | 2012-12-20 | $11.58 | $4K | N/A | N/A | N/A |
| XYL | SELL | 2012-09-14 | 2012-09-18 | $25.45 | $1.8M | -7.1% | +0.4% | +0.4% |
| XYL | SELL | 2012-09-12 | 2012-09-14 | $25.18 | $1.2M | -7.1% | +0.4% | +0.4% |
| XYL | SELL | 2012-09-07 | 2012-09-11 | $24.97 | $3.0M | -7.1% | +0.4% | +0.4% |
| XLS | SELL | 2012-03-06 | 2012-03-07 | $11.32 | $2.3M | N/A | N/A | N/A |
| XYL | SELL | 2012-02-09 | 2012-03-07 | $26.29 | $2.6M | -7.1% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.